This paper reported a newly designed retrievable urethral stent used in treatment of urethral strictures. The spiral urethral stent is made of Poly (l-lactide) (PLLA), adding barium sulphate (BaSO4) to certain content, which can be displayed precisely under X-ray after implanted in body. The stent was clinically tested in 32 patients with recurrent urethral strictures and was left in the urethra for 5 to 12 months. The response to the effect of the stent was assessed using symptom scores, peak flow rate (Qmax), residual urine volume (RUV), stent degradation, infection and outcome. During the treatment, there were not any inflammations found. The mechanical properties of the stent are almost the same as those of the PLLA stent without BaSO4. Improvements in patient symptom score, mean Qmax and RUV were significant at the 18 month follow-up. The infection was not observed. The stent was taken out easily through urethral forceps. In no patient was the stent obstructed by incrustation for up to 1.5 years.